POC Clinical Chemistry & Immunodiagnostics Market, 2020: Physician Offices, ERs, ORs, ICU/CCUs, Cancer Clinics, Nursing Homes, Ambulatory Care, Surgery & Birth Centers - ResearchAndMarkets.com

DUBLIN--()--The "2020 POC Clinical Chemistry and Immunodiagnostics Market: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts - Physician Offices, ERs, ORs, ICU/CCUs, Cancer Clinics, Nursing Homes, Ambulatory Care, Surgery and Birth Centers" report has been added to ResearchAndMarkets.com's offering.

This new 373-page report from the author contains 61 tables, and provides a comprehensive analysis of the POC clinical chemistry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC clinical chemistry market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

  • Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
  • Five-year test volume and reagent sales forecasts for clinical chemistry procedures by market segment.

Sales and Market Share Analysis

  • Sales and market shares of major clinical chemistry reagent and instrument suppliers.

Current and Emerging Products

  • Analysis of clinical chemistry procedures performed in POC testing locations.
  • Review of leading clinical chemistry analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.

Technology Review

  • Emerging technologies and their applications for POC testing.
  • Comprehensive listings of companies developing or marketing clinical Chemistry testing technologies and products, by assay.

Competitive Assessments

  • Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations

  • Specific opportunities for new clinical chemistry instruments and reagent systems with potentially significant market appeal during the next five years.
  • Design criteria for POC testing products.
  • Alternative business expansion strategies.
  • Potential market entry barriers and risks.

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • bioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken Chemical
  • Fujirebio
  • Grifols
  • Instrumentation Laboratory/Werfen
  • Kyowa Medex
  • Ortho-Clinical Diagnostics
  • PerkinElmer
  • Quest Diagnostics
  • Roche
  • Siemens Healthineers
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako

For more information about this report visit https://www.researchandmarkets.com/r/f05hvu

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900